RNA m6A的修改调节了瘤代谢和免疫之间的交叉交互
Jinghua Gu1,2, Huake Cao1,2, Xiaoli Chen3
1School of Life Sciences, Anhui Medical University, Hefei, China.
Wiley interdisciplinary reviews. RNA
|December 20, 2023
概括
N-甲基氨酸 (m6A) 修改影响癌细胞代谢和免疫细胞功能. 了解这些RNA变化,通过向瘤细胞行为和免疫力,为癌症提供了新的治疗策略.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
背景情况:
- 越来越多地认识到N-甲基氨酸 (m6A) RNA修饰在癌症中的作用.
- m6A影响瘤细胞代谢和瘤透免疫细胞的功能.
研究的目的:
- 审查RNA m6A修饰,瘤细胞代谢和免疫细胞行为之间的复杂联系.
- 探索相互调节轴:"RNA m6A-瘤细胞代谢-免疫细胞行为"和"RNA m6A-免疫细胞行为-瘤细胞代谢".
- 讨论影响瘤微环境中的m6A修饰的因素,包括缺氧和细胞因子.
主要方法:
- 文献综述和现有关于癌症m6A修饰现有研究的综合.
- 分析m6A,癌症代谢和免疫反应之间的相互作用.
- 讨论瘤微环境因素对m6A的影响.
主要成果:
- RNA m6A的修改对于调解瘤代谢和抗瘤免疫之间的相互作用至关重要.
- m6A 影响癌细胞代谢和免疫细胞的分化/活性.
- 瘤微环境中的缺氧和细胞因子会影响m6ARNA水平.
结论:
- RNA m6A的修改是癌症代谢和免疫之间的关键联系.
- 向m6A修改为新型癌症疗法提供了一个有希望的途径.
- 基于m6A的策略可以同时解决癌细胞恶性并增强抗瘤免疫力.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K


